Pulmonary Embolism Clinical Trial
Official title:
The Dating of Thrombus Organization in Cases of Pulmonary Embolism: an Autopsy Study
BACKGROUND: Pulmonary embolism (PE) is associated to high mortality rate worldwide. However,
the diagnosis of PE often results inaccurate. Many cases of PE are incorrectly diagnosed or
missed and they are often associated to sudden unexpected death (SUD). In forensic practice,
it is important to establish the time of thrombus formation in order to determine the precise
moment of death. The autopsy remains the gold standard method for the identification of death
cause allowing the determination of discrepancies between clinical and autopsy diagnoses. The
aim of our study will be to verify the morphological and histological criteria of fatal cases
of PE and evaluate the dating of thrombus formation considering 5 ranges of time.
METHODS: Pulmonary vessels sections will be collected from January 2010 to December 2017.
Sections of thrombus sampling will be stained with hematoxylin and eosin. The content of
infiltrated cells, fibroblasts and collagen fibers will be scored using a semi-quantitative
three-point scale of range values.
Hypothesis: After a macroscopic observation and a good sampling traditional histology, it
will be important to identify the time of thrombus formation. We will identify histologically
a range of time in the physiopathology of the thrombus (early, recent, recent-medium, medium,
old), allowing to determine the dating of thrombus formation and the exact time of death.
Introduction Venous thromboembolism (VTE) is pathological condition caused by deep vein
thrombosis (DVT) with a consequent detaching of thrombus from original sites , that by
embolic phenomena and traveling to the lung might result in pulmonary embolism (PE). As
first, the diagnosis of PE might result frequently inaccurate, with many cases incorrectly
diagnosed or missed. Secondly, it might be caused by several conditions such as surgery and
trauma, with a consequent relevant clinical impact and worse prognosis. However, clinical
presentation of PE range from those completely asymptomatic or with an insidious disease, to
sudden unexpected death (SUD. SUD may be defined as a natural and fatal event that occurs
within 1 h of the beginning of symptoms in an apparently healthy subject or in those with a
disease not particularly severe to cause an abrupt outcome. Since the diagnosis is
challenging, epidemiological data regarding PE mortality remain limited.To date, it is
estimated that PE is responsible for 100,000 annual deaths only in the United States and
approximately 25-30% of patients had SUD as consequence of PE.
However, in our opinion it might be essential to collect morphological macroscopic evaluation
elements to distinguish a thrombus from an embolus or agonic coagulum.To date, the autopsy
may be useful for the determination of the identification of death cause, and to establish
the dating of transformation of thrombus and evaluate any professional error. Therefore, in
this study, authors will critically review the histological section of thrombus from 30 fatal
cases of PE pulmonary embolus by autopsies, and its correlation and origin prior or
subsequent to a traumatic event, as confirmed by post-mortem examination and final diagnosis.
Moreover, the aim of this study will be to evaluate the chronological transformation of the
thrombus and to establish the time of death for each subject.
Materials and methods Patients and samples Pulmonary vessels sections will be collected from
30 fatal cases of PE (25 cases of hospitalized patients and 5 cases of SUD) defined according
to commonly accepted criteria were routinely collected from January 2010 to December 2017 at
the University of Naples Federico II.
Histological evaluation According to the guidelines for autopsy from the Association for
European Cardiovascular Pathology, and in all cases authors will examine the pulmonary
arterial trunk by posterior approach. Sections (4 μm thick) will be stained with hematoxylin
and eosin stain (H&E) for diagnosis. The original tissues samples will be fixed in 10%
neutral buffered formalin and embedded in paraffin. The immunohistochemistry for anti-LCA,
anti-CD68, and anti-CD3 will be performed to identify the inflammatory infiltrate. In
addition, authors will be performed an immunofluorescence method to identifying the
deposition of factor VIII and fibrinogen. A Picro Sirius Red/Fast Green will be used for
differential staining of collagen during matrix production phase. All stained samples will be
examined under infiltrate, absent or rare lympho-monocytic inflammatory elements. The vessels
of small and medium will be involved, mainly from the main branches of the pulmonary
vessels.In2 patients we observed a score 3 for cellular infiltrate and 1 for fibrosis. In 10
cases (5 heart patients, 2 cardiac patients undergoing surgery and 3 surgeries), authors will
observe an increase (score 2) in the digital and light microscope.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05050617 -
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
|
||
Terminated |
NCT04558125 -
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
|
Phase 4 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Completed |
NCT03915925 -
Short-term Clinical Deterioration After Acute Pulmonary Embolism
|
||
Completed |
NCT02502396 -
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
|
||
Recruiting |
NCT05171075 -
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
|
Phase 3 | |
Completed |
NCT04454554 -
Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
|
||
Completed |
NCT03173066 -
Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
|
Phase 1 | |
Terminated |
NCT03002467 -
Impact Analysis of Prognostic Stratification for Pulmonary Embolism
|
N/A | |
Completed |
NCT02334007 -
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT02611115 -
Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography.
|
N/A | |
Completed |
NCT01975090 -
The SENTRY Clinical Study
|
N/A | |
Not yet recruiting |
NCT01357941 -
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
|
N/A | |
Completed |
NCT01326507 -
Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism
|
N/A | |
Completed |
NCT00773448 -
Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism
|
N/A | |
Completed |
NCT00780767 -
Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism
|
Phase 2 | |
Completed |
NCT02476526 -
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00771303 -
Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
|
||
Completed |
NCT00720915 -
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
|
N/A | |
Completed |
NCT00816920 -
Natural History of Isolated Deep Vein Thrombosis of the Calf
|